Combining clinico-pathological features with pharmacogenetics in this chronic disease screening test is supported by the findings of Phipps et al. [32,33], who demonstrated subtype association with a family history of cancer and high BMI. In this study, two BRCA1/2 mutation-negative breast cancer...